HealthEquity, Inc. (NASDAQ:HQY) Q3 2025 Earnings Call Transcript
Q3 2025 Earnings Call Transcript December 10, 2024 Operator: Good afternoon, and welcome to the HealthEquity Third Quarter 2025 Earnings Conference Call. Please note this event is being recorded. I would now like to turn the conference over to Richard Putnam.
HealthEquity Inc (HQY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook
HealthEquity Inc (HQY) reports robust financial performance with a 21% revenue increase and raises fiscal guidance amid strategic expansions and challenges.
Earnings Summary: HealthEquity Q3
HealthEquity beat estimated earnings by 8.0%, reporting an EPS of $0.78 versus an estimate of $0.72. Revenue was up $51.21 million from the same period last year.
HealthEquity: Fiscal Q3 Earnings Snapshot
HealthEquity expects full-year earnings in the range of $3.08 to $3.16 per share, with revenue in the range of $1.19 billion to $1.2 billion. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HQY at https://www.zacks.com/ap/HQY
HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat
HQY's fiscal third-quarter results benefit from robust HSA growth and improved gross margin. It also raises fiscal 2025 guidance.
HealthEquity Earnings Analysis: Q3 Recap
HealthEquity HQY announced its Q3 earnings on Monday, December 9, 2024 at 04:01 PM. Here's a breakdown of the earnings report. HealthEquity beat estimated earnings by 8.0%, reporting an EPS of $0.78 versus an estimate of $0.72.
HealthEquity, Inc. Shows Strong Q3 Financial Growth
Healthequity Inc ( (HQY) ) has released its Q3 earnings. Here is a breakdown of the information Healthequity Inc presented to its
HealthEquity (HQY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
HealthEquity (HQY) reported $300.43 million in revenue for the quarter ended October 2024, representing a year-over-year increase of 20.6%. EPS of $0.78 for the same period compares to $0.60 a year ago.
Healthequity’s Strong Performance and Promising Outlook Justifies Buy Rating
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on HQY stock, giving a Buy rating yesterday.Pick the best ...
HealthEquity Stock Falls on Disappointing Outlook
Key Takeaways HealthEquity shares fell Tuesday after the company's full-year profit and sales outlook missed analysts' ...
HealthEquity (HQY) Set to Announce Quarterly Earnings on Monday
HealthEquity (NASDAQ:HQY – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on ...
Healthequity (HQY) Receives a Buy from RBC Capital
RBC Capital analyst Sean Dodge reiterated a Buy rating on Healthequity (HQY – Research Report) today and set a price target of $105.00. The ...
Yahoo Finance3d
HealthEquity, Inc. (HQY)
HealthEquity Inc (HQY) reports robust financial performance with a 21% revenue increase and raises fiscal guidance amid strategic expansions and challenges. While the top- and bottom-line numbers ...
Yahoo23d
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
HQY is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of A and VGM Score of B. Earnings are expected to grow 37.3% year-over-year for the current fiscal year, with sales growth of 18.2%.
Leadership Change at Healthequity Inc.: Challenges and Risks as Scott Cutler Steps In as CEO
Healthequity Inc (HQY) has disclosed a new risk, in the Corporate Activity and Growth category.Pick the best stocks and maximize your ...